WithdrawnNot Applicable

Baroreflex Activation Therapy in Left Ventricular Assist Device Patients Study

Stopped: Study not moving forward due to unable to identify patients who qualify.

0Started 2025-07-01

Plain-language summary

This study will involve LVAD patients who have already received a clinically-indicated BAT (BAROSTIM) device. After recovery from LVAD implant, we will investigate the effects of BAT in a double-blind cross-over study design.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \> 18 years * LVAD patient \> 3 months post implant * Existing BAT device Exclusion Criteria: * Presence of cardiogenic shock, respiratory failure, hypotension or unstable heart failure * Bradycardia (resting HR \<60 beats/minute) * Presence of suspected pump thrombosis at the time of enrollment * Presence of any significant ventricular arrhythmias at the time of enrollment

What they're measuring

6 Minute Hall Walk

Timeframe: 3 months

Trial details

NCT IDNCT06195046

SponsorMedical University of South Carolina

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-01

View on ClinicalTrials.gov More Congestive Heart Failure trials